Edwards Lifesciences (EW) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.49% |
| Dec 31, 2025 | -15.53% |
| Sep 30, 2025 | -3.01% |
| Jun 30, 2025 | 34.63% |
| Mar 31, 2025 | 1.97% |
| Dec 31, 2024 | 0.12% |
| Sep 30, 2024 | 3.56% |
| Jun 30, 2024 | 6.50% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | 132.15% |
| Sep 30, 2023 | 8.01% |
| Jun 30, 2023 | 0.89% |
| Mar 31, 2023 | 8.99% |
| Dec 31, 2022 | -10.07% |
| Sep 30, 2022 | 13.46% |
| Jun 30, 2022 | 13.78% |
| Mar 31, 2022 | 8.02% |
| Dec 31, 2021 | 13.22% |
| Sep 30, 2021 | 15.62% |
| Jun 30, 2021 | 21.30% |
| Mar 31, 2021 | 15.04% |
| Dec 31, 2020 | 14.97% |
| Sep 30, 2020 | 18.09% |
| Jun 30, 2020 | -25.84% |
| Mar 31, 2020 | 16.71% |
| Dec 31, 2019 | 15.61% |
| Sep 30, 2019 | 17.84% |
| Jun 30, 2019 | 17.53% |
| Mar 31, 2019 | 24.01% |
| Dec 31, 2018 | -15.39% |
| Sep 30, 2018 | 18.73% |
| Jun 30, 2018 | 14.79% |
| Mar 31, 2018 | 17.34% |
| Dec 31, 2017 | 20.77% |
| Sep 30, 2017 | 17.73% |
| Jun 30, 2017 | 20.26% |
| Mar 31, 2017 | 28.21% |
| Dec 31, 2016 | 18.39% |
| Sep 30, 2016 | 25.82% |
| Jun 30, 2016 | 47.57% |
| Mar 31, 2016 | 19.41% |
| Dec 31, 2015 | 16.76% |
| Sep 30, 2015 | 18.24% |
| Jun 30, 2015 | 58.56% |
| Mar 31, 2015 | 21.41% |
| Dec 31, 2014 | 18.50% |
| Sep 30, 2014 | 18.09% |
| Jun 30, 2014 | 13.80% |